Cargando…
Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis
Osteoarthritis (OA) affects over 40 million people annually. We evaluated interleukin-1 receptor antagonist (IL-1ra) gene transfer in an equine model based on IL-1ra protein therapy which inhibits inflammation through blocking IL-1. Using the self-complementary adeno-associated virus (scAAV)IL-1ra e...
Autores principales: | Goodrich, Laurie R, Phillips, Jennifer N, McIlwraith, C Wayne, Foti, Stacey B, Grieger, Joshua C, Gray, Steven J, Samulski, R Jude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586798/ https://www.ncbi.nlm.nih.gov/pubmed/23385523 http://dx.doi.org/10.1038/mtna.2012.61 |
Ejemplares similares
-
Gene therapy approaches for equine osteoarthritis
por: Thampi, Parvathy, et al.
Publicado: (2022) -
Corrigendum: Gene therapy approaches for equine osteoarthritis
por: Thampi, Parvathy, et al.
Publicado: (2023) -
Adeno-Associated Viral Vectors Show Serotype Specific Transduction of Equine Joint Tissue Explants and Cultured Monolayers
por: Hemphill, Daniel D., et al.
Publicado: (2014) -
Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model
por: Wang, Gensheng, et al.
Publicado: (2016) -
Induction of Synovitis Using Interleukin-1 Beta: Are There Differences in the Response of Middle Carpal Joint Compared to the Tibiotarsal Joint?
por: Colbath, Aimee C., et al.
Publicado: (2018)